Overview

The Post-Vitrectomy Lenstatin™ Study

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

To determine the efficacy of Lenstatin™, an over-the-counter nutritional supplement, in inhibiting the progression of nuclear cataract in eyes after pars plana vitrectomy.

Phase:

N/A

Details

Lead Sponsor:

Lenstatin LLC